MEA Spinal Implants Market

MEA Spinal Implants Market Size (2023 to 2028)

The Middle East & Africa Spinal Implants Market size is valued at USD 293.04 million in 2023 and is expected to grow at a CAGR of 2.82% to reach USD 336.75 million by 2028.

Most of the surgeries are not needed in spinal conditions/disorders; however, there are times when they cannot be avoided. When that happens, these deformities are corrected using specially designed spinal instruments that strengthen and stabilize the spine and facilitate fusion. Stainless steel or titanium-alloy are generally used to make spinal implants. However, sometimes non-metallic compounds are also used.

Augmenting the geriatric and obese population, technological advancements in spine surgery devices, rising incidence and prevalence of spinal disorders, and growing demand for minimally invasive spine surgery are the primary factors driving the growth of this market.

Cumbersome and stringent processes and regulatory frameworks in developed countries for the approval of products, uncertainty in reimbursement, and high cost of treatment procedures are a few of the inhibitors' market growth. Further, secondary factors like lack of patient awareness about the newly developed spine treatment procedures coupled with a paucity of adequate physician education and government cost-containment measures also restrain the market growth.

This research report on the Middle East and African spinal implants market has been segmented and sub-segmented into the following categories:

By Technology: 

• Spinal Fusion and Fixation Technologies
• Vertebral Compression Fracture Treatment
• Motion Preservation/Non-Fusion Technologies
• Spinal Decompression

By Product: 

• Thoracic Fusion and Lumbar Fusion Devices                                             
• Posterior Thoracic Fusion and Lumbar Fusion Devices                      
• Interbody Thoracic Fusion and Lumbar Fusion Devices                    
  • By Approach   
  • Anterior Lumbar Interbody Fusion Devices
  • Posterior Lumbar Interbody Fusion Devices
  • Transforaminal Lumbar Interbody Fusion Devices
  • Axial Lumbar Interbody Fusion Devices
  • By Material      
  • Non-Bone Interbody Fusion Devices
  • Bone Interbody Fusion Devices
  • Anterior Thoracic Fusion and Lumbar Fusion Devices    
• Cervical Fusion Devices                  
  • Anterior Cervical Fusion             
  • Anterior Cervical Plates
  • Cervical Interbody Fusion Devices
  • Anterior Cervical Screw Systems
  • Posterior Cervical Fusion           
  • Posterior Cervical Plates
  • Posterior Cervical Screws
  • Posterior Cervical Rods
• Spine Biologics                   
  • Demineralized Bone Matrix      
  • Bone Morphogenetic Proteins
  • Bone Substitutes          
  • Machined Bones           
  • Cell-Based Matrices     
  • Allografts          
• Vcf Treatment Devices                   
  • Balloon Kyphoplasty Devices   
  • Vertebroplasty Devices              
• Spinal Decompression                    
  • Discectomy      
  • Laminoplasty, Laminectomy, and Laminotomy
  • Foraminotomy and Foraminectomy     
  • Facetectomy   
  • Corpectomy    
• Non-Fusion Devices                        
  • Dynamic Stabilization Devices  
  • Interspinous Process Spacers
  • Pedicle-Based Dynamic Rod Devices
  • Facet Replacement Products
  • Artificial Discs  
  • Artificial Cervical Discs
  • Artificial Lumbar Discs
  • Annulus Repair Devices              
  • Nuclear Disc Prostheses             
• Spine Bone Stimulators                  
  • Non-Invasive Spine Bone Stimulators  
  • Pulsed Electromagnetic Field Devices
  • Cc and Cmf Devices
  • Invasive Spine Bone Stimulators

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Based on region, it is the last in terms of market share. On the other hand, UAE is the leading market in this region.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the MEA spinal implants market profiled in this report are Medtronic, plc (Ireland), DePuy Synthes (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V. (Netherlands), K2M Group Holdings, Inc. (U.S.), and RTI Surgical, Inc. (U.S.).